Will triumph over misdiagnosis
On-screen Text:
WILL
TRIUMPH OVER MISDIAGNOSIS .
NARRATOR (VO):
We invited one dermatologist and four patients to speak openly about psoriasis.
On-screen Text:
Dr. Ackerman is a paid consultant for AbbVie.
On-screen Text:
Patients were on prescribed SKYRIZI (risankizumab-rzaa) therapy at the time of providing a testimonial. Changes in therapy may have occurred since that time. Individual results may vary.
WILL (VO):
I was misdiagnosed when I was 16 years old.
On-screen Text:
WILL
Diagnosed with moderate plaque psoriasis
WILL (VO):
They told me it was dermatitis.
On-screen Text:
WILL
SKYRIZI patient since 2024
WILL (VO):
They would give me a cream and just tell me to see how that worked. It never worked.
WILL (VO):
At first, I didn’t really…
On-screen Text:
SKYRIZI is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy).
WILL (VO):
…think much of it. It was just a little patch, and then, uh, gradually it got bigger.
WILL (VO):
16, you’re in high school.
On-screen Text:
Please keep watching for Important Safety Information.
WILL (VO):
I would get teased a lot…
ALISHA (VO):
You’re okay.
SELINA (VO):
You’re okay.
DIRECTOR OFF CAMERA (VO):
Do you want to stop?
WILL (VO):
No, I’m good.
WILL (VO):
Share some details…
WILL (VO):
…about your experience if you believe the color of your skin played a role in your misdiagnosis.
WILL (VO):
As a person of color, the way psoriasis presented on my skin...
WILL (VO):
...isn’t the way that it presents in typical textbooks.
ALISHA (VO):
Yeah. I wish that there would have been better representation in expressing how psoriasis shows up in a person of color.
WILL (VO):
I had a PA...
WILL (VO):
…who was really, really adamant about getting to the bottom of my issue. And finally, after about…
WILL (VO):
three months, we narrowed it down,…
WILL (VO):
…and he told me I had psoriasis.
WILL (VO):
I went from one treatment to another…
WILL (VO):
…until I found something that was gonna work for me.
WILL (VO):
What was your A-HA moment when SKYRIZI started working for you?
WILL (VO):
Dr. Ackerman prescribed SKYRIZI for me. I was…
On-screen Text:
Will and his doctor discussed the side effects, risks, and safety profile of SKYRIZI.
WILL (VO):
…trying to find a medicine that could handle…
WILL (VO):
…my plaque psoriasis and I found SKYRIZI, and it’s working.
On-screen Text:
In clinical trials, 3 out of 4 people on SKYRIZI achieved 90% clearer skin at 4 months.
WILL (VO):
When I came back to see you, I was like hey, you know, things are good.
DR. ACKERMAN (VO):
I love walking into the room when that’s been the case. It’s a good vibe.
WILL (VO):
I noticed that my skin was improving with SKYRIZI...
WILL (VO):
...when I was out hiking and doing photography.
WILL (VO):
And there was no flaking.
WILL (VO):
I was looking for answers…I found it with SKYRIZI.
On-screen Text:
Please keep watching for Important Safety Information.
WILL (VO):
I’m very happy with the results.
V.O./On-screen Text:
IMPORTANT SAFETY INFORMATION AND USE
SKYRIZI® (risankizumab-rzaa) USE
SKYRIZI is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy).
Important Safety Information
What is the most important information I should know about SKYRIZI® (risankizumab-rzaa)?
SKYRIZI is a prescription medicine that may cause serious side effects, including:
Serious allergic reactions:
- Stop using SKYRIZI and get emergency medical help right away if you get any of the following symptoms of a serious allergic reaction:
- fainting, dizziness, feeling lightheaded (low blood pressure)
- swelling of your face, eyelids, lips, mouth, tongue, or throat
- trouble breathing or throat tightness
- chest tightness
- skin rash, hives
- itching
Infections:
SKYRIZI may lower the ability of your immune system to fight infections and may increase your risk of infections. Your healthcare provider should check you for infections and tuberculosis (TB) before starting treatment with SKYRIZI and may treat you for TB before you begin treatment with SKYRIZI if you have a history of TB or have active TB. Your healthcare provider should watch you closely for signs and symptoms of TB during and after treatment with SKYRIZI.
- Tell your healthcare provider right away if you have an infection or have symptoms of an infection, including:
- fever, sweats, or chills
- cough
- shortness of breath
- blood in your mucus (phlegm)
- muscle aches
- warm, red, or painful skin or sores on your body different from your psoriasis
- weight loss
- diarrhea or stomach pain
- burning when you urinate or urinating more often than normal
Do not use SKYRIZI if you are allergic to risankizumab-rzaa or any of the ingredients in SKYRIZI. See the Medication Guide or Consumer Brief Summary for a complete list of ingredients.
Before using SKYRIZI, tell your healthcare provider about all of your medical conditions, including if you:
- have any of the conditions or symptoms listed in the section “What is the most important information I should know about SKYRIZI?”
- have an infection that does not go away or that keeps coming back.
- have TB or have been in close contact with someone with TB.
- have recently received or are scheduled to receive an immunization (vaccine). Medications that interact with the immune system may increase your risk of getting an infection after receiving live vaccines. You should avoid receiving live vaccines right before, during, or right after treatment with SKYRIZI. Tell your healthcare provider that you are taking SKYRIZI before receiving a vaccine.
- are pregnant or plan to become pregnant. It is not known if SKYRIZI can harm your unborn baby.
- are breastfeeding or plan to breastfeed. It is not known if SKYRIZI passes into your breast milk.
- become pregnant while taking SKYRIZI. You are encouraged to enroll in the Pregnancy Registry, which is used to collect information about the health of you and your baby. Talk to your healthcare provider or call 1-877-302-2161 to enroll in this registry.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of SKYRIZI?
SKYRIZI may cause serious side effects. See “What is the most important information I should know about SKYRIZI?”
The most common side effects of SKYRIZI in people treated for plaque psoriasis and psoriatic arthritis include: upper respiratory infections, headache, feeling tired, injection site reactions, and fungal skin infections.
These are not all the possible side effects of SKYRIZI. Call your doctor for medical advice about side effects.
Use SKYRIZI exactly as your healthcare provider tells you to use it.
SKYRIZI is available in a 150 mg/mL prefilled syringe and pen.
Please see the Full Prescribing Information, including the Medication Guide, for SKYRIZI.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
if you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.
© 2025 AbbVie. All rights reserved. SKYRIZI® and its design are registered trademarks of AbbVie Biotechnology Ltd.
US-SKZD-250112